Cytosorbents
CTSO
$0.82
Share price
1.24%
Change (1 day)
-66.71%
Change (1 year)
Categories
P/S ratio for Cytosorbents (CTSO)
P/S ratio as of April 2024 (TTM): 1.42
According to Cytosorbents's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.42034. At the end of 2023 the company had a P/S ratio of 1.86.
P/S ratio history for Cytosorbents from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.86 | -19.13% |
| 2022 | 2.30 | -49.28% |
| 2021 | 4.54 | -47.98% |
| 2020 | 8.73 | 58.3% |
| 2019 | 5.52 | -56.49% |
| 2018 | 12.7 | -9.04% |
| 2017 | 13.9 | -17.61% |
| 2016 | 16.9 | -51.5% |
| 2015 | 34.9 | -52.7% |
| 2014 | 73.7 | 92.9% |
| 2013 | 38.2 | |
| 2012 | N/A | -100% |
| 2011 | 787 | |
| 2010 | N/A | |
| 2009 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | 7.56 | 431.95% | 🇺🇸 USA |
 Hologic HOLX | 4.50 | 216.64% | 🇺🇸 USA |
 Meridian Bioscience VIVO | 4.47 | 214.76% | 🇺🇸 USA |